The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response

Genes and Development - Tập 19 Số 19 - Trang 2278-2283 - 2005
Hideki Inoue1, Naoki Hisamoto2, Jae Hyung An, Riva de Paula Oliveira3, Eisuke Nishida4, T. Keith Blackwell3, Kunihiro Matsumoto2
1Department of Molecular Biology, Graduate School of Science, Institute for Advanced Research, Nagoya University, Chikusa-ku, Nagoya 464-8602, Japan
2Department of Molecular Biology, Graduate School of Science, Institute for Advanced Research, Nagoya University, and CREST, Japan Science and Technology Corporation, Chikusa-ku, Nagoya 464-8602, Japan
3Section of Developmental and Stem Cell Biology, Joslin Diabetes Center and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215, USA;
4Department of Cell and Developmental Biology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan

Tóm tắt

The evolutionarily conserved p38 mitogen-activated protein kinase (MAPK) cascade is an integral part of the response to a variety of environmental stresses. Here we show that the Caenorhabditis elegans PMK-1 p38 MAPK pathway regulates the oxidative stress response via the CNC transcription factor SKN-1. In response to oxidative stress, PMK-1 phosphorylates SKN-1, leading to its accumulation in intestine nuclei, where SKN-1 activates transcription of gcs-1, a phase II detoxification enzyme gene. These results delineate the C. elegans p38 MAPK signaling pathway leading to the nucleus that responds to oxidative stress.

Từ khóa


Tài liệu tham khảo

10.1101/gad.1107803

10.1006/mcbr.2001.0300

10.1051/medsci/20031967725

10.1038/35065000

10.1101/gad.1276505

2004, Nature Immun., 5, 488, 10.1038/ni1060

10.1006/dbio.1995.1225

10.1016/S0304-3835(01)00695-4

10.1101/gad.13.1.76

10.1126/science.1072682

10.1093/emboj/18.13.3604

10.1126/science.1073759

2001, Physiol. Rev., 81, 807, 10.1152/physrev.2001.81.2.807

10.1073/pnas.0308625101

10.1016/S0092-8674(04)00203-X

1991, EMBO J., 10, 3959, 10.1002/j.1460-2075.1991.tb04966.x

2004, Trend Mol. Med., 10, 549, 10.1016/j.molmed.2004.09.003

10.1038/18465

10.1016/S0092-8674(01)00313-0

10.1093/embo-reports/kvf001

10.1074/jbc.M001746200

10.1073/pnas.0500660102